Last reviewed · How we verify
NCT04023799: CUPID
Couple User Preferences in Dual Purpose Prevention Products
trial in HIV Prevention in 400 participants. Completed in 5 November 2020.
5 November 2020
Quick facts
| Lead sponsor | Microbicide Trials Network |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 21 January 2020 |
| Primary completion | 5 November 2020 |
| Estimated completion | 5 November 2020 |
| Sites | 2 locations across Zimbabwe, Uganda |
Conditions studied
- HIV Prevention — all drugs for HIV Prevention →
- Contraception Behavior — all drugs for Contraception Behavior →
Sponsor
Microbicide Trials Network
Who can join
Adults 18 to 40, any sex, with HIV Prevention or Contraception Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
MTN-045 is a cross-sectional study that will utilize questionnaires, including Discrete-Choice Experiments (DCE) and joint decision tasks, to assess couples' preferences related to dual purpose prevention (DPP) products that could be used to prevent unintended pregnancies and HIV infection. Post-survey explanatory in-depth interviews (IDIs) will be conducted with a subset of participants to explore DPP product-related decisions..
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04023799
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for HIV Prevention
Currently open trials in the same condition.
- NCT07194902 — HIV Self-testing for Partners of HIV-uninfected Postpartum Women · NA · recruiting
- NCT07218211 — Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP · Phase 4 · recruiting
- NCT07349758 — Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers · Phase 1 · recruiting
- NCT07433985 — California MEPS Hub · NA · recruiting
- NCT07002866 — Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda · NA · recruiting
Other Microbicide Trials Network trials
Trials by the same sponsor.
- NCT03671239 — Rectal Microbicide Acceptability, Tolerability and Adherence · NA · completed
- NCT03648931 — Microbicide/PrEP Acceptability Among Mothers and Male Partners in Africa · completed
- NCT02702895 — Assessment of ASPIRE and HOPE Adherence · completed
- NCT01209754 — EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure) · completed
- NCT00514098 — Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04023799 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Microbicide Trials Network
- Last refreshed: 13 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04023799.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing